Des nodules, encores des nodules… : infection à mycobactérie atypique chez un patient porteur d’un syndrome myélodysplasique
M. Guille(Institut universitaire du cancer de Toulouse Oncopole), Odile Beyne‐Rauzy(Université Paris-Sud), K. Delavigne(Human Technopole), Pierre Cougoul(Hôpital Purpan), Thibault Comont(Institut universitaire du cancer de Toulouse Oncopole), S. Ollier(Institut universitaire du cancer de Toulouse Oncopole), Sarah Guenounou(Institut universitaire du cancer de Toulouse Oncopole), X. Boumaza(Institut universitaire du cancer de Toulouse Oncopole)
Cited by 0
Related Papers
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
|Journal of Clinical Oncology|2013|543
Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias
|Leukemia|2011|464
Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience
|Blood|2007|332
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)
|Blood|2009|270
Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults
|Journal of Thrombosis and Haemostasis|2018|138